Literature DB >> 16184436

The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods.

Balázs Jójárt1, Tamás A Martinek, Arpád Márki.   

Abstract

Molecular docking and 3D-QSAR studies were performed to determine the binding mode for a series of benzoxazine oxytocin antagonists taken from the literature. Structural hypotheses were generated by docking the most active molecule to the rigid receptor by means of AutoDock 3.05. The cluster analysis yielded seven possible binding conformations. These structures were refined by using constrained simulated annealing, and the further ligands were aligned in the refined receptor by molecular docking. A good correlation was found between the estimated deltaG(bind) and the pKi values for complex F. The Connolly-surface analysis, CoMFA and CoMSIA models q2(CoMFA) = 0.653, q2(CoMSA) = 0.630 and r2(pred,CoMFA) = 0.852 , r2(pred,CoMSIA) = 0.815) confirmed the scoring function results. The structural features of the receptor-ligand complex and the CoMFA and CoMSIA fields are in closely connected. These results suggest that receptor-ligand complex F is the most likely binding hypothesis for the studied benzoxazine analogs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16184436     DOI: 10.1007/s10822-005-7137-0

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  21 in total

Review 1.  Functional architecture of vasopressin/oxytocin receptors.

Authors:  M Hibert; J Hoflack; S Trumpp-Kallmeyer; B Mouillac; B Chini; E Mahé; N Cotte; S Jard; M Manning; C Barberis
Journal:  J Recept Signal Transduct Res       Date:  1999 Jan-Jul       Impact factor: 2.092

2.  A molecular model of agonist and nonpeptide antagonist binding to the human V(1) vascular vasopressin receptor.

Authors:  M Thibonnier; P Coles; D M Conarty; C L Plesnicher; M Shoham
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

3.  Structure-activity relationship investigations of a potent and selective benzodiazepine oxytocin antagonist.

Authors:  P G Wyatt; M J Allen; J Chilcott; G Hickin; N D Miller; P M Woollard
Journal:  Bioorg Med Chem Lett       Date:  2001-05-21       Impact factor: 2.823

4.  Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency.

Authors:  P D Williams; M G Bock; B E Evans; R M Freidinger; S N Gallicchio; M T Guidotti; M A Jacobson; M S Kuo; M R Levy; E V Lis; S R Michelson; J M Pawluczyk; D S Perlow; D J Pettibone; A G Quigley; D R Reiss; C Salvatore; K J Stauffer; C J Woyden
Journal:  Bioorg Med Chem Lett       Date:  1999-05-03       Impact factor: 2.823

5.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction.

Authors:  Renxiao Wang; Luhua Lai; Shaomeng Wang
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

Review 6.  G protein-coupled receptors. II. Mechanism of agonist activation.

Authors:  U Gether; B K Kobilka
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

7.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

8.  Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.

Authors:  I M Bell; J M Erb; R M Freidinger; S N Gallicchio; J P Guare; M T Guidotti; R A Halpin; D W Hobbs; C F Homnick; M S Kuo; E V Lis; D J Mathre; S R Michelson; J M Pawluczyk; D J Pettibone; D R Reiss; S Vickers; P D Williams; C J Woyden
Journal:  J Med Chem       Date:  1998-06-04       Impact factor: 7.446

9.  OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.

Authors:  Y Yamamura; H Ogawa; T Chihara; K Kondo; T Onogawa; S Nakamura; T Mori; M Tominaga; Y Yabuuchi
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

10.  Alpha-adrenergic blockade: a possible mechanism of tocolytic action of certain benzodiazepines in a postpartum rat model in vivo.

Authors:  István Zupkó; Kinga Jánossy; Katalin Maul; Arpád Márki; George Falkay
Journal:  Life Sci       Date:  2003-01-24       Impact factor: 5.037

View more
  2 in total

1.  Possible dynamic anchor points in a benzoxazinone derivative-human oxytocin receptor system--a molecular docking and dynamics calculation.

Authors:  Balázs Jójárt; Arpád Márki
Journal:  J Mol Model       Date:  2006-05-05       Impact factor: 1.810

2.  Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors.

Authors:  Marcin Hoffmann; Krystian Eitner; Marcin von Grotthuss; Leszek Rychlewski; Ewa Banachowicz; Tomasz Grabarkiewicz; Tomasz Szkoda; Andrzej Kolinski
Journal:  J Comput Aided Mol Des       Date:  2006-09-14       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.